(The Center Square) – Global consulting firm McKinsey & Company Inc. agreed to pay $650 million to resolve a criminal and civil investigation into the firm's work with opioid maker Purdue Pharma. McKinsey advised Purdue on steps to 'turbocharge' sales of OxyContin, a powerful and addictive extended-release opioid, according to the U.S. Department of Justice. […]
The post McKinsey to pay $650 million for role in opioid crisis appeared first on The Black Chronicle.
